Monisha Ashok, Director of Health Investments, U.S. International Development Finance Corporation (DFC): DFC's "strategy refresh" elevates health as a priority.

Monisha Ashok, Director of Health Investments, U.S. International Development Finance Corporation (DFC) lays out how health now figures in DFC's strategy following the late 2025 Congressional reauthorization that increased its investment cap by more than threefold to $205 billion with much greater flexibilities, including equity investments and engagement in high-income countries. Under the DFC "strategy refresh," health has been elevated as a priority, with special emphasis on supply chain resilience and biosecurity. There is enormous market concentration of active pharmaceutical ingredients (APIs) and key starting materials (KSM) in China, where investments in near- or friend-shores production are essential to create more diverse and resilient supply chains. Biosecurity encompasses medical countermeasures (vaccines, therapies, tests); labs and advanced diagnostics; and bio surveillance. Increasingly, DFC is drawn to support the many signed MOUs with partner countries, under the America First Global Health Strategy. During the General Assembly in New York the week of September 21, DFC will join a panel on the first anniversary of AFGHA and a roundtable on financing pandemic preparedness and response.